Recent Finacing
Recent Raise
Tiburio Therapeutics is a Cambridge-based biopharmaceutical company developing licensed compounds TBR-760 (for non-functioning pituitary adenoma) and TBR-065 for rare endocrine diseases, advancing clinical proof-of-concept.
